Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jan 02, 2024

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Carrier Global Dividend	Maximilian Viessmann	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	58,608,959	58,608,959	-		-	Common Stock
Selecta Biosciences Inc	Carsten Brunn	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	5,971,000	5,971,000	-		-	Employee Stock Option (right to buy)
Selecta Biosciences Inc	Carsten Brunn	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	4,654,100	4,916,056 (5%)	5%		0	Common Stock
Selecta Biosciences Inc	Davis Blaine	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	3,110,000	3,110,000	-		-	Employee Stock Option (right to buy)
Roivant Sciences Ltd	Ramaswamy Vivek	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 11.05 per share.	02 Jan 2024	3,000,000	51,929,426	-	11.1	33,150,000	Common Shares
Selecta Biosciences Inc	Davis Blaine	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	2,424,000	2,424,000 (2%)	2%		0	Common Stock
Selecta Biosciences Inc	Kurtoglu Metin	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	1,965,000	1,965,000	-		-	Employee Stock Option (right to buy)
Selecta Biosciences Inc	Kurtoglu Metin	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	1,531,000	1,531,000 (1%)	1%		0	Common Stock
Gossamer Bio Inc	Faheem Hasnain	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	1,312,500	1,312,500	-		-	Stock Option (Right to Buy)
Bumble Inc (Class A)	Lidiane Jones	Director, Chief Executive Officer		02 Jan 2024	1,207,226	1,207,226	-		-	Stock Option (right to buy)
Taysha Gene Therapies Inc	P. Sean Nolan	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	1,184,688	1,185,858	-		0	Common Stock
Taysha Gene Therapies Inc	P. Sean Nolan	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	1,184,688	1,184,688	-		-	Employee Stock Option (right to buy)
BlackBerry Ltd	John J. Giamatteo	Director, CEO & President, Cybersecurity	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	1,005,830	1,005,830	-		-	Restricted Share Units
Selecta Biosciences Inc	Jewell M. Christopher	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	998,000	998,000	-		-	Employee Stock Option (right to buy)
Green Brick Partners Inc	David Einhorn M.	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 46.24 per share.	02 Jan 2024	937,500	1,802,690 (3%)	1%	46.2	43,353,000	Common Stock
JBG SMITH Properties	Kelly W. Matthew	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	923,482	2,403,446	-		-	AO LTIP
Taysha Gene Therapies Inc	Sukumar Nagendran	Director, President and Head of R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	863,617	897,843	-		0	Common Stock
Taysha Gene Therapies Inc	Sukumar Nagendran	Director, President and Head of R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	863,617	863,617	-		-	Employee Stock Option (right to buy)
La Rosa Holdings Corp Results	Joseph La Rosa	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	800,000	800,000	-		-	Stock Option (Right to Buy)
Selecta Biosciences Inc	Jewell Christopher M.	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	778,200	778,200 (0%)	0%		0	Common Stock
Bumble Inc (Class A)	Jones Lidiane	Director, Chief Executive Officer		02 Jan 2024	748,351	748,351	-		0	Class A Common Stock
Selecta Biosciences Inc	Miljkovic Milos	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	703,000	703,000	-		-	Employee Stock Option (right to buy)
Pacira BioSciences Inc	Lee Frank D.	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	692,512	692,512	-		-	Stock Option (Right to Buy)
Newmark Grp Inc (Class A)	W. Lutnick Howard	Director, Executive Chairman, Ten Percent Owner		02 Jan 2024	617,262	896,987	-		-	Newmark Holdings Exchangeable Limited Partnership Interests
Acumen Pharma Inc	O'Connell Daniel	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	602,000	602,000	-		-	Employee Stock Option (right to buy)
Taysha Gene Therapies Inc	Kamran Alam	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	590,413	590,413	-		-	Employee Stock Option (right to buy)
Taysha Gene Therapies Inc	Alam Kamran	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	590,413	842,225	-		0	Common Stock
Kura Oncology Inc	Wilson Troy E.	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	560,000	560,000	-		-	Option to purchase common stock
Selecta Biosciences Inc	Milos Miljkovic	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	548,200	548,200 (0%)	0%		0	Common Stock
Gossamer Bio Inc	Giraudo Bryan	COO/CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	543,750	543,750	-		-	Stock Option (Right to Buy)
ORIC Pharma Inc	Jacob M. Chacko	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	510,000	510,000	-		-	Stock Option (right to buy)
Atlassian Corp (Class A)	Cannon-Brookes Michael	Director, Co-CEO, Co-Founder, Ten Percent Owner		02 Jan 2024	502,701	502,701 (0%)	0%		-	Class A Common Stock
Atlassian Corp (Class A)	Farquhar Scott	Director, Co-CEO, Co-Founder, Ten Percent Owner		02 Jan 2024	502,701	502,701 (0%)	0%		-	Class A Common Stock
Atlassian Corp (Class A)	Cannon-Brookes Michael	Director, Co-CEO, Co-Founder, Ten Percent Owner		02 Jan 2024	502,701	51,020,984	-		-	Class B Common Stock
Atlassian Corp (Class A)	Scott Farquhar	Director, Co-CEO, Co-Founder, Ten Percent Owner		02 Jan 2024	502,701	51,020,984	-		-	Class B Common Stock
Ocugen Inc	Musunuri Shankar	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	492,126	492,126	-		-	Option (Right to Buy)
Gossamer Bio Inc	Richard Aranda	Chief Medical Officer		02 Jan 2024	487,500	487,500	-		-	Stock Option (Right to Buy)
Barinthus Biotherapeutics PLC. (ADR)	William J. Enright	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	443,981	443,981	-		-	Share Option (Right to Buy)
Werewolf Therapeutics Inc	Hicklin, Daniel J.	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	435,000	435,000	-		-	Stock Option (right to buy)
UDR Dividend	Toomey Thomas W.	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	420,438	953,872	-		-	Class 2 LTIP Units
Equillium Inc	Steel D. Bruce	Director, President and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	410,000	410,000	-		-	Employee Stock Option (right to buy)
Acumen Pharma Inc	Daniel O'Connell	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	401,000	517,685	-		0	Common Stock
Gossamer Bio Inc	Christian Waage	EVP, Tech Ops and Admin	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	375,000	375,000	-		-	Stock Option (Right to Buy)
Gossamer Bio Inc	Caryn Peterson	EVP, Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	375,000	375,000	-		-	Stock Option (Right to Buy)
Janux Therapeutics Inc	Campbell David	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	356,500	356,500	-		-	Stock Option (right to buy)
Design Therapeutics Inc	Jeffries Sean	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	350,000	350,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Justin Chakma	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	350,000	350,000	-		-	Stock option (right to buy)
ARS Pharma Inc	Dorsey Brian T.	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	350,000	350,000	-		-	Stock option (right to buy)
Monte Rosa Therapeutics Inc	Warmuth Markus	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	346,000	346,000	-		-	Stock Option (Right to Buy)
Protagonist Therapeutics Inc	V. Dinesh Patel	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	315,250	315,250	-		-	Stock Option (right to buy)
Regenxbio Inc High Loss High Volume	Mills Kenneth T.	Director, President and CEO		02 Jan 2024	305,250	305,250	-		-	Stock Options (Right to buy)
ARS Pharma Inc	Alexander A. Fitzpatrick	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	300,000	300,000	-		-	Stock option (right to buy)
Biohaven Ltd	Coric Vlad	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	275,000	275,000	-		-	Stock Options (Right to buy)
Sempra Energy	W. Martin Jeffrey	Director, Chairman, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	258,166	258,166	-		-	Employee Stock Option (right to buy)
Regions Financial Results Board Meeting 10-year high	Russell K. Zusi	SEVP & CRO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	256,410	256,410	-		-	Restricted Stock Units
LXP Industrial Trust	Eglin T. Wilson	Director, Chairman, CEO and President	Sale or transfer of securities back to the company at price $ 9.92 per share.	02 Jan 2024	252,260	2,664,503 (1%)	0%	9.9	2,502,419	Common Shares
Capricor Therapeutics Inc	Marban Linda	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	250,000	250,000	-		-	Stock Option (Right to Buy)
Catalyst Pharma Inc	McEnany J. Patrick	Director, Chairman of Board of Directors	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.13 per share.	02 Jan 2024	250,000	4,385,256 (4%)	0%	1.1	282,500	Common stock, par value $0.001 per share
Catalyst Pharma Inc	McEnany J. Patrick	Director, Chairman of Board of Directors	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	250,000	2,735,745	-		-	Options to purchase common stock
Selecta Biosciences Inc	S. Carrie Cox	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	248,000	248,000	-		-	Stock Option (Right to Buy)
Sanmina Corp	Jure Sola	Chairman & CEO	Grant, award, or other acquisition of securities at price $ 50.41 per share.	02 Jan 2024	240,000	1,278,984 (1%)	0%	50.4	12,098,400	Common Stock
JBG SMITH Properties	Kevin Reynolds	Chief Development Officer		02 Jan 2024	237,467	607,457	-		-	AO LTIP
Royalty Pharma PLC (Class A)	Rory B. Riggs	Director		02 Jan 2024	235,200	254,899	-	28.5	6,707,081	Class A Ordinary Shares
CenterPoint Energy	David Lesar J.	Director, CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.01 per share.	02 Jan 2024	231,123	1,077,399 (0%)	0%	29.0	6,704,878	Common Stock
MFA Fin Inc	Knutson Craig L.	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	230,721	1,245,954	-		-	Phantom Shares
Selecta Biosciences Inc	Kalayoglu Murat	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	228,000	228,000	-		-	Stock Option (Right to Buy)
Selecta Biosciences Inc	Sallin Aymeric	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	228,000	228,000	-		-	Stock Option (Right to Buy)
Selecta Biosciences Inc	Zenner J. Patrick	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	228,000	228,000	-		-	Stock Option (Right to Buy)
Selecta Biosciences Inc	Timothy Springer A.	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	228,000	228,000	-		-	Stock Option (Right to Buy)
Selecta Biosciences Inc	de Silva Nishan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	228,000	228,000	-		-	Stock Option (Right to Buy)
Selecta Biosciences Inc	Barabe Timothy C.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	228,000	228,000	-		-	Stock Option (Right to Buy)
Aqua Metals Inc	Cotton Stephen	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.79 per share.	02 Jan 2024	220,103	6,202,233 (10%)	0%	0.8	173,881	Common Stock
Gaming and Leisure Properties Inc	Peter Carlino M.	Director, Chairman,CEO,President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	220,000	5,939,406 (2%)	0%		0	Common Stock
JBG SMITH Properties	Matthew Kelly W.	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	217,797	1,702,543	-		-	LTIP Units
JBG SMITH Properties	George Laucks Xanders	Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	211,081	477,848	-		-	AO LTIP
JBG SMITH Properties	Madhumita Moina Banerjee	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	207,783	499,216	-		-	AO LTIP
Global Indemnity Grp LLC (Class A)	Joseph W. Brown	Director, Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	200,000	400,000	-		-	Option to Purchase Class A Common Shares (right to buy)
Capricor Therapeutics Inc	Litvack Frank	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	200,000	200,000	-		-	Stock Option (Right to Buy)
Dyadic Intl Inc, DE	A. Emalfarb Mark	Director, President and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	200,000	200,000	-		-	Stock Option
Werewolf Therapeutics Inc	Randi Isaacs	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	200,000	200,000	-		-	Stock Option (right to buy)
ProMIS Neurosciences Inc	Neil Warma K.	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	200,000	208,333	-		-	Option (right to buy)
ARS Pharma Inc	Karas Eric	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	200,000	200,000	-		-	Stock option (right to buy)
ARS Pharma Inc	Kathleen Scott D.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	200,000	200,000	-		-	Stock option (right to buy)
Royalty Pharma PLC (Class A)	Riggs B. Rory	Director		02 Jan 2024	199,098	55,801	-	27.8	5,532,276	Class A Ordinary Shares
Barinthus Biotherapeutics PLC. (ADR)	Gemma Brown	Chief Financial Officer		02 Jan 2024	193,000	193,000	-		-	Share Option (Right to Buy)
Kura Oncology Inc	Dale Stephen	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	185,000	185,000	-		-	Option to purchase common stock
Kura Oncology Inc	Ford Kathleen	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	185,000	185,000	-		-	Option to purchase common stock
Reliance Global Grp Inc 10-year low	Joel Markovits	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	185,000	253,572 (0%)	0%		0	Common Stock
Imax Corp Analyst Downgrade	Gelfond Richard L.	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	183,578	183,578	-		-	restricted share units
Alpha & Omega Semiconductor Ltd	F. Mike Chang	Director, Executive Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	180,000	4,517,591 (18%)	0%		0	Common Shares
ORIC Pharma Inc	G. Dominic Piscitelli	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	180,000	180,000	-		-	Stock Option (right to buy)
ORIC Pharma Inc	Multani Pratik S.	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	180,000	180,000	-		-	Stock Option (right to buy)
Selecta Biosciences Inc	C. Timothy Barabe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	178,000	428,013 (0%)	0%		0	Common Stock
Selecta Biosciences Inc	Carrie Cox S.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	178,000	390,881 (0%)	0%		0	Common Stock
Selecta Biosciences Inc	Sallin Aymeric	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	178,000	178,000 (0%)	0%		0	Common Stock
Selecta Biosciences Inc	Zenner Patrick J.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	178,000	233,248 (0%)	0%		0	Common Stock
Selecta Biosciences Inc	Timothy Springer A.	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	178,000	7,471,625 (8%)	0%		0	Common Stock
Selecta Biosciences Inc	Nishan de Silva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	178,000	185,000 (0%)	0%		0	Common Stock
Selecta Biosciences Inc	Kalayoglu Murat	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	178,000	435,739 (0%)	0%		0	Common Stock
Equillium Inc	Connelly Stephen	Director, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	175,000	175,000	-		-	Employee Stock Option (right to buy)
Equillium Inc	Rothman Joel	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	175,000	175,000	-		-	Employee Stock Option (right to buy)
Equillium Inc	Zedelmayer Christine	Sr. Vice President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	175,000	175,000	-		-	Employee Stock Option (right to buy)
Equillium Inc	A. Jason Keyes	Chief Financial Officer		02 Jan 2024	175,000	175,000	-		-	Employee Stock Option (right to buy)
Magnite Inc	Michael Barrett G.	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	169,173	169,173	-		-	Performance Stock Units
Magnite Inc	L. David Day	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	161,247	568,346 (1%)	0%		0	Common Stock
Coherus Biosciences Inc	Reider Paul	Chief Commercial Officer		02 Jan 2024	160,000	160,000	-		-	Stock Option (Right to Buy)
Archer Aviation Inc (Class A)	Lore E. Marc	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 5.90 per share.	02 Jan 2024	160,000	27,926,358	-	5.9	943,296	Class A Common Stock
JBG SMITH Properties	Steven Museles A.	Chief Legal Off. & Corp Secy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	157,651	390,744	-		-	AO LTIP
Janux Therapeutics Inc	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		02 Jan 2024	157,000	157,000	-		-	Stock Option (right to buy)
Bicycle Therapeutics PLC (ADR)	Kevin Lee	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	155,000	155,000	-		-	Employee Stock Option (right to buy)
Janux Therapeutics Inc	Robinson Byron	Chief Strategy Officer		02 Jan 2024	151,500	151,500	-		-	Stock Option (right to buy)
Amprius Tech Inc	Bornstein Jonathan	President of Amprius Lab		02 Jan 2024	150,000	1,433,851	-		-	Stock Option (right to buy)
Amprius Tech Inc	Bornstein Jonathan	President of Amprius Lab		02 Jan 2024	150,000	150,000	-	0.1	7,500	Common stock
Werewolf Therapeutics Inc	Cynthia Seidel-Dugan	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	150,000	150,000	-		-	Stock Option (right to buy)
Werewolf Therapeutics Inc	Timothy Trost W.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	150,000	150,000	-		-	Stock Option (right to buy)
Werewolf Therapeutics Inc	Karunatilake Chulani	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	150,000	150,000	-		-	Stock Option (right to buy)
Kratos Defense & Security Soln Inc	Eric Demarco M.	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	150,000	150,000	-		-	Restricted Stock Units
Janux Therapeutics Inc	DiRaimondo Thomas	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	147,000	147,000	-		-	Stock Option (right to buy)
Magnite Inc	Patrick Sean Buckley	Chief Revenue Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	142,276	454,727 (0%)	0%		0	Common Stock
MFA Fin Inc	Knutson Craig L.	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	142,223	1,015,233	-		-	Phantom Shares
Acumen Pharma Inc	Siemers Eric	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	141,000	141,000	-		-	Employee Stock Option (right to buy)
Levi Strauss & Co. - Ordinary Shares Cls A	D. Gass Michelle	Director, President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.26 per share.	02 Jan 2024	138,707	353,993 (0%)	0%	16.3	2,255,376	Class A Common Stock
Ocugen Inc	Arun Upadhyay	See Remarks		02 Jan 2024	137,795	137,795	-		-	Option (Right to Buy)
Acumen Pharma Inc	M. Derek Meisner	Chief Legal Officer & Corp Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	137,000	137,000	-		-	Employee Stock Option (right to buy)
BGC Grp Inc (Class A)	Stephen M. Merkel	EVP and General Counsel	Sale of securities on an exchange or to another person at price $ 0.00 per share.	02 Jan 2024	136,891	9,618 (0%)	0%		-	Class A Common Stock, par value $0.01 per share
Werewolf Therapeutics Inc	Lubman Ellen	Chief Business Officer		02 Jan 2024	131,900	131,900	-		-	Stock Option (right to buy)
Kraft Heinz	Miguel Patricio Nuno Da Mata	Director		02 Jan 2024	131,500	992,049 (0%)	0%	38.0	4,999,025	Common Stock
FG Fin Grp Inc	Swets G. Larry	Director, Chief Executive Officer		02 Jan 2024	130,000	130,000	-		-	Stock option
Goosehead Insurance Inc (Class A)	Jones Mark E.	Director, CEO, Ten Percent Owner, Member of 10% owner group	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	130,000	130,000	-		-	Employee Stock Options (right to buy)
Magnite Inc	Barrett Michael G.	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	129,870	129,870	-		-	Stock Option (Right to Buy)
UDR Dividend	Joseph Fisher D.	President-CFO		02 Jan 2024	129,132	387,321	-		-	Class 2 LTIP Units
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Aron M. Adam	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	126,328	492,664 (0%)	0%		0	Class A Common Stock
Anavex Life Sciences Corp	U. Missling Christopher	Director, President and CEO		02 Jan 2024	125,000	125,000	-		-	Stock Option (Right to Buy)
Coherus Biosciences Inc	J. Bryan McMichael	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	125,000	125,000	-		-	Stock Option (Right to Buy)
Amprius Tech Inc	Jonathan Bornstein	President of Amprius Lab		02 Jan 2024	124,634	25,366	-	4.3	538,182	Common stock
Magnite Inc	G. Barrett Michael	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	121,951	1,329,792 (2%)	0%		0	Common Stock
Monte Rosa Therapeutics Inc	Janku Filip	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	121,000	121,000	-		-	Stock Option (Right to Buy)
Monte Rosa Therapeutics Inc	Owen Wallace	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	119,000	119,000	-		-	Stock Option (Right to Buy)
Sanmina Corp	Jure Sola	Chairman & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.41 per share.	02 Jan 2024	118,818	1,160,166 (1%)	0%	50.4	5,989,615	Common Stock
BlackBerry Ltd	Mattias Eriksson	President of IoT		02 Jan 2024	116,618	116,618	-		-	Restricted Share Units
Ionis Pharma Inc	Brett Monia P.	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	116,580	116,580	-		-	Non-Qualified Stock Option (right to buy)
UDR Dividend	Thomas W. Toomey	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	116,193	1,070,065	-		-	Class 2 LTIP Units
Magnite Inc	Lee Adam Soroca	Chief Product Officer		02 Jan 2024	113,821	532,683 (0%)	0%		0	Common Stock
Magnite Inc	Evans Katie	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	113,821	456,054 (0%)	0%		0	Common Stock
Janux Therapeutics Inc	Winter M. Charles	Chief Technical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	111,000	111,000	-		-	Stock Option (right to buy)
Acumen Pharma Inc	Barton Russell	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	110,000	110,000	-		-	Employee Stock Option (right to buy)
Design Therapeutics Inc	Julie Burgess	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	110,000	110,000	-		-	Stock Option (right to buy)
Monte Rosa Therapeutics Inc	Nickson Philip	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	109,000	109,000	-		-	Stock Option (Right to Buy)
Absci Corp	Pangalos Menelas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	106,200	106,200	-		-	Stock Option (right to buy)
Janux Therapeutics Inc	Meyer Hollman Andrew	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	105,000	105,000	-		-	Stock Option (right to buy)
Barinthus Biotherapeutics PLC. (ADR)	Nadege Pelletier	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	105,000	105,000	-		-	Share Option (Right to Buy)
BlackBerry Ltd	Steve Rai	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	102,040	102,040	-		-	Restricted Share Units
Cadence Design High Loss High Volume	Ligtenberg Adriaan	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	99,886	0	-		-	Non- Qualified Stock Option (right to buy)
Cadence Design High Loss High Volume	Ligtenberg Adriaan	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.58 per share.	02 Jan 2024	99,886	239,234 (0%)	0%	39.6	3,953,488	Common Stock
Pacira BioSciences Inc	Lee Frank D.	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	99,520	99,520 (0%)	0%		0	Common Stock
MFA Fin Inc	Gudmundur Kristjansson	SVP & Co-Chief Invest. Ofcr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	99,499	480,529	-		-	Phantom Shares
MFA Fin Inc	Bryan Wulfsohn	SVP & Co-Chief Invest. Ofcr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	99,499	480,529	-		-	Phantom Shares
Symbotic Inc (Class A)	Dunn Michael	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	99,156	106,935	-		-	Class A Common Stock
Symbotic Inc (Class A)	Michael Dunn	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	99,156	99,157	-		-	Restricted Stock Units
Aqua Metals Inc	B. Judd Merrill	Chief Financial Officer		02 Jan 2024	98,215	2,138,916 (3%)	0%	0.8	77,590	Common Stock
Barinthus Biotherapeutics PLC. (ADR)	Graham Griffiths	Chief Business Officer		02 Jan 2024	96,500	96,500	-		-	Share Option (Right to Buy)
Biohaven Ltd	Gentile Kimberly	SVP, Clinical Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	96,250	96,250	-		-	Stock Options (Right to buy)
Biohaven Ltd	Buten Matthew	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	96,250	96,250	-		-	Stock Options (Right to buy)
Biohaven Ltd	Car Bruce	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	96,250	96,250	-		-	Stock Options (Right to buy)
Gaming and Leisure Properties Inc	M. Peter Carlino	Director, Chairman,CEO,President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.35 per share.	02 Jan 2024	95,854	5,843,552 (2%)	0%	49.4	4,730,395	Common Stock
Glaukos Corp	Thomas Burns W.	Director, CHAIRMAN & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	95,000	60,115	-		-	Stock Option (Right to Buy)
Glaukos Corp	Burns W. Thomas	Director, CHAIRMAN & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.28 per share.	02 Jan 2024	95,000	150,835 (0%)	0%	7.3	691,125	Common Stock
Halliburton Analyst Upgrade Results Board Meeting	Jeffrey A. Miller	Director, Director, President & CEO	Grant, award, or other acquisition of securities at price $ 36.12 per share.	02 Jan 2024	94,208	772,067 (0%)	0%	36.1	3,402,793	Common Stock
Acumen Pharma Inc	Siemers Eric	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	94,000	120,700	-		0	Common Stock
Kura Oncology Inc	Bair Brophy Teresa	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	92,500	92,500	-		-	Option to purchase common stock
Acumen Pharma Inc	Meisner Derek M.	Chief Legal Officer & Corp Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	91,000	117,800	-		0	Common Stock
UDR Dividend	Harry G. Alcock	SVP-Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	90,093	473,877	-		-	Class 2 LTIP Units
Alpha & Omega Semiconductor Ltd	Chunping Stephen Chang	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	90,000	467,637 (1%)	0%		0	Common Share
Alpha & Omega Semiconductor Ltd	Liang Yifan	CFO and Corp Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	90,000	301,504 (1%)	0%		0	Common Shares
Alpha & Omega Semiconductor Ltd	Xue Bing	EVP-WW Sales & Bus Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	90,000	155,132 (0%)	0%		0	Common Share
Spar Grp Inc Results	Brown Robert G.	Director, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	02 Jan 2024	90,000	2,870,996 (13%)	0%		-	Common Stock, $.01 par value
UDR Dividend	D. Joseph Fisher	President-CFO		02 Jan 2024	88,528	475,849	-		-	Class 2 LTIP Units
Full House Resorts Inc	Daniel Lee R.	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	87,822	87,822	-		-	Employee Stock Option (Right to Buy)
Magnite Inc	David Buonasera	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	85,058	290,639 (0%)	0%		0	Common Stock
Capricor Therapeutics Inc	Bergmann J. Anthony	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	85,000	85,000	-		-	Stock Option (Right to Buy)
ORIC Pharma Inc	M. Jacob Chacko	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	85,000	85,000	-		-	Restricted Stock Unit
Protagonist Therapeutics Inc	Patel Dinesh V.	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	84,875	619,222 (2%)	0%		0	Common Stock
Wheeler Real Estate Investment Trust Inc	Stilwell Joseph D.	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	02 Jan 2024	84,470	84,470	-		-	Series D Convertible Preferred Stock
Celcuity Inc FDA Approval	Brian F. Sullivan	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	84,000	84,000	-		-	Stock Option (right to buy)
Terex Corp	L. Garrison John	Former DIR, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.46 per share.	02 Jan 2024	81,141	410,980 (0%)	0%	57.5	4,662,362	Common Stock, par value $.01
Capricor Therapeutics Inc	Karen Krasney G.	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	80,000	80,000	-		-	Stock Option (Right to Buy)
Goosehead Insurance Inc (Class A)	Miller K. Mark	Director, President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	80,000	80,000	-		-	Employee Stock Options (right to buy)
Easterly Government Properties Inc	W. Crate Darrell	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	79,423	79,423	-		-	LTIP Units
Bullfrog AI Holdings Inc	Singh Vininder	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	79,000	79,000	-		-	Stock options (Right to buy)
Monte Rosa Therapeutics Inc	Jullian G. Jones	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	79,000	79,000	-		-	Stock Option (Right to Buy)
JBG SMITH Properties	W. Kelly Matthew	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	78,836	1,781,379	-		-	LTIP Units
Protagonist Therapeutics Inc	Asif Ali	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	78,000	78,000	-		-	Stock Option (right to buy)
Mitek Systems Inc	Lyle B. David	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	77,386	77,386	-		-	Performance Restricted Stock Units
Sempra Energy	Trevor I. Mihalik	EVP and Group Pres	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	77,095	77,095	-		-	Employee Stock Option (right to buy)
Bicycle Therapeutics PLC (ADR)	Kevin Lee	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	77,000	399,131	-		0	Ordinary Shares
Bicycle Therapeutics PLC (ADR)	Alistair Milnes	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	77,000	77,000	-		-	Employee Stock Option (right to buy)
Samsara Inc (Class A)	Sanjit Biswas	Director, Chief Executive Officer, Ten Percent Owner		02 Jan 2024	76,800	17,235,364	-		-	Class B Common Stock
Samsara Inc (Class A)	John Bicket	Director, See remarks, Ten Percent Owner		02 Jan 2024	76,800	76,800	-		0	Class A Common Stock
Samsara Inc (Class A)	John Bicket	Director, See remarks, Ten Percent Owner		02 Jan 2024	76,800	17,235,364	-		-	Class B Common Stock
Samsara Inc (Class A)	Sanjit Biswas	Director, Chief Executive Officer, Ten Percent Owner		02 Jan 2024	76,800	76,800	-		0	Class A Common Stock
ACV Auctions Inc (Class A)	Craig Anderson	CCDSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	76,703	98,297	-		-	Employee Stock Option (Right to Buy)
ACV Auctions Inc (Class A)	Anderson Craig	CCDSO	Sale of securities on an exchange or to another person at price $ 14.89 per share.	02 Jan 2024	76,703	199,781	-	14.9	1,142,108	Class A Common Stock
ACV Auctions Inc (Class A)	Craig Anderson	CCDSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	76,703	276,484	-		-	Class A Common Stock
ACV Auctions Inc (Class A)	Anderson Craig	CCDSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	76,703	204,019	-		-	Class B Common Stock
ACV Auctions Inc (Class A)	Anderson Craig	CCDSO		02 Jan 2024	76,703	127,316	-		-	Class B Common Stock
Regenxbio Inc High Loss High Volume	Vittal Vasista	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	76,313	76,313	-		-	Stock Options (Right to buy)
UDR Dividend	Michael Lacy D.	SVP-Property Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	75,073	244,070	-		-	Class 2 LTIP Units
Dyadic Intl Inc, DE	Hazelton Joseph	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	75,000	75,000	-		-	Stock Option
Dyadic Intl Inc, DE	Rawson W. Ping	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	75,000	75,000	-		-	Stock Option
eHealth Inc	Barbeau Michelle	Chief Revenue Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	75,000	221,425 (0%)	0%		0	Common Stock
Kratos Defense & Security Soln Inc	Lund Deanna H.	Director, EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	75,000	75,000	-		-	Restricted Stock Units
Kratos Defense & Security Soln Inc	H. Lund Deanna	Director, EVP & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	75,000	250,478 (0%)	0%		0	Common Stock
Kratos Defense & Security Soln Inc	H. Deanna Lund	Director, EVP & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	75,000	0	-		-	Restricted Stock Units
Samsara Inc (Class A)	Sanjit Biswas	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 31.73 per share.	02 Jan 2024	74,500	2,300	-	31.7	2,364,064	Class A Common Stock
Samsara Inc (Class A)	John Bicket	Director, See remarks, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 31.72 per share.	02 Jan 2024	73,300	3,500	-	31.7	2,324,981	Class A Common Stock
Acumen Pharma Inc	Barton Russell	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	73,000	99,700	-		0	Common Stock
Protagonist Therapeutics Inc	Gupta Suneel	Chief Development Officer		02 Jan 2024	71,500	71,500	-		-	Stock Option (right to buy)
Hertz Global Holdings Inc - Ordinary Shares (New)	Keppy Justin	Executive Vice President, COO		02 Jan 2024	70,806	1,777,291 (1%)	0%		0	Common Stock
Gaming and Leisure Properties Inc	Moore Brandon John	COO, Gen Counsel & Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	70,000	306,559 (0%)	0%		0	Common Stock
International Money Express Inc	Lisy Robert	Director, CEO, President & Chairman	Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.09 per share.	02 Jan 2024	69,426	298,984 (0%)	0%	22.1	1,533,620	Common Stock
QuantumScape Corp (Class A) 10-year low	Straubel B. Jeffrey	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share.	02 Jan 2024	69,309	361,953	-	2.4	164,747	Class A Common Stock
QuantumScape Corp (Class A) 10-year low	Jeffrey B. Straubel	Director	Sale of securities on an exchange or to another person at price $ 6.75 per share.	02 Jan 2024	69,309	292,644	-	6.7	467,718	Class A Common Stock
QuantumScape Corp (Class A) 10-year low	B. Straubel Jeffrey	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	69,309	589,571	-		-	Stock Option (right to buy)
Symbotic Inc (Class A)	Dunn Michael	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	69,099	69,100	-		-	Restricted Stock Units
Symbotic Inc (Class A)	Michael Dunn	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	69,099	176,034	-		-	Class A Common Stock
Neurocrine Biosciences Inc	Gano Kyle W.	Chief Business Development Off	Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.59 per share.	02 Jan 2024	68,884	199,134 (0%)	0%	19.6	1,349,438	Common Stock
Neurocrine Biosciences Inc	Kyle W. Gano	Chief Business Development Off	Sale of securities on an exchange or to another person at price $ 131.47 per share.	02 Jan 2024	68,884	130,250 (0%)	0%	131.5	9,056,290	Common Stock
Neurocrine Biosciences Inc	W. Gano Kyle	Chief Business Development Off	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	68,884	0	-		-	Non-Qualified Stock Option
Dyadic Intl Inc, DE	Tarnok P. Michael	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	67,500	67,500	-		-	Stock Option
Dyadic Intl Inc, DE	Bose Arindam	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	67,500	67,500	-		-	Stock Option
Dyadic Intl Inc, DE	Jack Kaye L.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	67,500	67,500	-		-	Stock Option
Pentair Negative Outlook	John Stauch L.	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	67,157	67,157	-		-	Employee Stock Option (right to buy)
Edison International	Pizarro J. Pedro	Director, PRESIDENT AND CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	65,879	0	-		-	Non-qualified Stock Options (Right to Buy)
Edison International	Pizarro Pedro J.	Director, PRESIDENT AND CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.48 per share.	02 Jan 2024	65,879	203,963 (0%)	0%	65.5	4,313,757	Common Stock
LXP Industrial Trust	Bonventre Joseph S.	EVP, COO, Gen.Counsel & Sec	Sale or transfer of securities back to the company at price $ 9.92 per share.	02 Jan 2024	65,402	615,616 (0%)	0%	9.9	648,788	Common Shares
Ginkgo Bioworks Holdings Inc (Class A)	Dmytruk Mark	See remarks		02 Jan 2024	65,284	742,128	-		-	Class A Common Stock
Ginkgo Bioworks Holdings Inc (Class A)	Dmytruk Mark	See remarks		02 Jan 2024	65,284	908,783	-		-	Restricted Stock Units
Goosehead Insurance Inc (Class A)	Jones Mark E.	Chief Financial Officer, Ten Percent Owner, Member of 10% owner group	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	65,000	65,000	-		-	Employee Stock Options (right to buy)
e.l.f. Beauty Inc	Scott K. Milsten	See remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	64,939	32,342	-		-	Stock Option (Right to Buy) (Common Stock)
e.l.f. Beauty Inc	Scott K. Milsten	See remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share.	02 Jan 2024	64,939	144,043 (0%)	0%	17	1,103,963	Common Stock, $0.01 par value
Regenxbio Inc High Loss High Volume	Mills T. Kenneth	Director, President and CEO		02 Jan 2024	64,103	408,035 (1%)	0%		0	Common Stock
Kingstone Cos. Inc	Golden Meryl S.	Director, CEO, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	64,085	232,044 (2%)	0%		0	Common Stock
Gaming and Leisure Properties Inc	Burke Desiree A.	CFO and Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	64,000	175,761 (0%)	0%		0	Common Stock
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Aron M. Adam	Director, Chairman, President & CEO		02 Jan 2024	63,292	0	-		-	Restricted Stock Units
Magnite Inc	Saltz Aaron	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	62,602	334,519 (0%)	0%		0	Common Stock
Imax Corp Analyst Downgrade	Gelfond L. Richard	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	62,528	125,057	-		-	restricted share units
Imax Corp Analyst Downgrade	Gelfond L. Richard	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	62,528	474,173 (0%)	0%		0	common shares
Edison International	Pedro J. Pizarro	Director, PRESIDENT AND CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.34 per share.	02 Jan 2024	61,981	141,982 (0%)	0%	72.3	4,483,706	Common Stock
MFA Fin Inc	Gudmundur Kristjansson	SVP & Co-Chief Invest. Ofcr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	61,334	381,030	-		-	Phantom Shares
MFA Fin Inc	Bryan Wulfsohn	SVP & Co-Chief Invest. Ofcr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	61,334	381,030	-		-	Phantom Shares
Regenxbio Inc High Loss High Volume	Simpson Curran	Chief Oper. & Tech. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	61,050	61,050	-		-	Stock Options (Right to buy)
Regenxbio Inc High Loss High Volume	Danos Olivier	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	61,050	61,050	-		-	Stock Options (Right to buy)
Equitable Holdings Inc	Mark Pearson	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 33.07 per share.	02 Jan 2024	60,000	639,625 (0%)	0%	33.1	1,984,116	Common Stock
Catalyst Pharma Inc	Charles O'Keeffe B.	Director		02 Jan 2024	60,000	681,724 (0%)	0%	1.1	67,800	Common Stock, par value $0.001 per share
Catalyst Pharma Inc	Charles B. O'Keeffe	Director		02 Jan 2024	60,000	232,931	-		-	Options to purchase common stock
Credo Tech Grp Holding Ltd	Chi Fung Cheng	Director, Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 18.51 per share.	02 Jan 2024	60,000	10,768,602	-	18.5	1,110,510	Ordinary Shares
Gaming and Leisure Properties Inc	Demchyk J. Matthew	SVP, Chief Investment Officer		02 Jan 2024	60,000	107,904 (0%)	0%		0	Common Stock
Photronics Inc	Burr E. Richelle	EVP, CAO & General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	60,000	286,733 (0%)	0%		0	Common Stock
Zentalis Pharma Inc High Gain High Volume	Mark Lackner	Chief Scientific Officer		02 Jan 2024	60,000	60,000	-		-	Stock Option (Right to Buy)
Anterix Inc	R. Kuhn Thomas	Director, Vice Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	58,998	58,998	-		-	Stock Option (Right to Buy)
American Well Corp (Class A) High Gain High Volume	Paunovich Vukasin	EVP, Enterprise Platforms		02 Jan 2024	58,409	615,312	-	1.1	62,445	Class A Common Stock
BlackBerry Ltd	Philip S. Kurtz	CLO & Corp. Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	58,309	58,309	-		-	Restricted Share Units
Mitek Systems Inc	Lyle B. David	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 12.89 per share.	02 Jan 2024	58,185	58,185 (0%)	0%	12.9	750,005	Common Stock
Symbotic Inc (Class A)	Dunn Michael	See Remarks	Sale of securities on an exchange or to another person at price $ 45.54 per share.	02 Jan 2024	57,940	42,016	-	45.5	2,638,617	Class A Common Stock
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Adam M. Aron	Director, Chairman, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	02 Jan 2024	57,826	434,838 (0%)	0%		0	Class A Common Stock
Strata Critical Medical Inc (Class A)	William Heyburn A.	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	57,686	350,000	-		-	Stock Option (right to buy)
Strata Critical Medical Inc (Class A)	Heyburn William A.	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share.	02 Jan 2024	57,686	1,388,310	-	0.2	10,383	Class A common stock, $0.0001 par value per share
Magnite Inc	Day L. David	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	57,519	57,519	-		-	Performance Stock Units
Symbotic Inc (Class A)	Michael Dunn	See Remarks	Sale of securities on an exchange or to another person at price $ 46.35 per share.	02 Jan 2024	57,324	118,710	-	46.3	2,656,870	Class A Common Stock
LXP Industrial Trust	Brendan Mullinix P.	EVP & Chief Investment Officer	Sale or transfer of securities back to the company at price $ 9.92 per share.	02 Jan 2024	56,059	493,712 (0%)	0%	9.9	556,105	Common Shares
JBG SMITH Properties	Kevin Reynolds	Chief Development Officer		02 Jan 2024	56,004	433,292	-		-	LTIP Units
Sun Communities Inc	A. Shiffman Gary	Director, Chairman, President & CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	02 Jan 2024	56,000	847,574 (0%)	0%		0	COMMON STOCK, $0.01 PAR VALUE
Bicycle Therapeutics PLC (ADR)	Michael Skynner	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	56,000	56,000	-		-	Employee Stock Option (right to buy)
Bicycle Therapeutics PLC (ADR)	Nicholas Keen	Chief Scientific Officer		02 Jan 2024	56,000	56,000	-		-	Employee Stock Option (right to buy)
Nextracker Inc (Class A)	Paul R. Lundstrom	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	55,009	55,009	-		0	Common Stock
Gaming and Leisure Properties Inc	Peter Carlino M.	Director, Chairman,CEO,President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	55,000	5,719,406 (2%)	0%		0	Common Stock
Regenxbio Inc High Loss High Volume	Christmas Patrick J.	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	54,945	54,945	-		-	Stock Options (Right to buy)
Fastenal	Daniel Florness L.	Director, CEO AND PRESIDENT	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	54,687	54,687	-		-	Employee Stock Option (Right to Buy)
WEC Energy	Scott Lauber J.	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	54,598	54,598	-		-	Stock Option (right to buy)
UDR Dividend	Harry Alcock G.	SVP-Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	53,946	527,823	-		-	Class 2 LTIP Units
ACV Auctions Inc (Class A)	Anderson Craig	CCDSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	52,849	252,630	-		-	Class A Common Stock
ACV Auctions Inc (Class A)	Craig Anderson	CCDSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	52,849	180,165	-		-	Class B Common Stock
ACV Auctions Inc (Class A)	Craig Anderson	CCDSO		02 Jan 2024	52,849	127,316	-		-	Class B Common Stock
ACV Auctions Inc (Class A)	Anderson Craig	CCDSO	Sale of securities on an exchange or to another person at price $ 14.89 per share.	02 Jan 2024	52,849	199,781	-	14.9	786,922	Class A Common Stock
ACV Auctions Inc (Class A)	Craig Anderson	CCDSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	52,849	103,063	-		-	Employee Stock Option (Right to Buy)
Airbnb	Chesky Brian	Director, CEO and Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 134.46 per share.	02 Jan 2024	52,586	15,289,102	-	134.5	7,070,829	Class A Common Stock
Imax Corp Analyst Downgrade	Gelfond L. Richard	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	52,084	0	-		-	restricted share units
Imax Corp Analyst Downgrade	Gelfond Richard L.	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	52,084	491,077 (0%)	0%		0	common shares
Ventas 10-year high	Cafaro A. Debra	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 50.57 per share.	02 Jan 2024	52,056	909,446 (0%)	0%	50.6	2,632,472	Common Stock
Glaukos Corp	Burns W. Thomas	Director, CHAIRMAN & CEO	Sale of securities on an exchange or to another person at price $ 76.69 per share.	02 Jan 2024	51,764	99,071 (0%)	0%	76.7	3,969,781	Common Stock
Cadence Design High Loss High Volume	Adriaan Ligtenberg	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 262.99 per share.	02 Jan 2024	51,681	157,445 (0%)	0%	263.0	13,591,586	Common Stock
Imax Corp Analyst Downgrade	L. Gelfond Richard	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	51,382	440,060 (0%)	0%		0	common shares
Imax Corp Analyst Downgrade	Gelfond Richard L.	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	51,382	51,383	-		-	restricted share units
Regenxbio Inc High Loss High Volume	Pakola Steve	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	50,875	50,875	-		-	Stock Options (Right to buy)
Magnite Inc	Patrick Buckley Sean	Chief Revenue Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	50,752	50,752	-		-	Performance Stock Units
Magnite Inc	Gephart Brian	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	50,667	144,989 (0%)	0%		0	Common Stock
Spok Holdings Inc Board Meeting	Vincent Kelly D.	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.48 per share.	02 Jan 2024	50,523	296,515 (1%)	0%	15.5	782,096	Common Stock
Vince Holding Corp	John Szczepanski	Chief Financial Officer		02 Jan 2024	50,000	50,000 (0%)	0%		0	Common Stock
Dyadic Intl Inc, DE	K. Patrick Lucy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	50,000	50,000	-		-	Stock Option
Dyadic Intl Inc, DE	J. Seth Herbst	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	50,000	50,000	-		-	Stock Option
Dyadic Intl Inc, DE	Barry Buckland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	50,000	50,000	-		-	Stock Option
Equillium Inc	M. Bradbury Daniel	Director, Executive Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	50,000	50,000	-		-	Employee Stock Option (right to buy)
Kratos Defense & Security Soln Inc	M. Demarco Eric	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	50,000	0	-		-	Restricted Stock Units
Kratos Defense & Security Soln Inc	Eric M. Demarco	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	50,000	804,748 (0%)	0%		0	Common Stock
Upstart Holdings Inc	Paul Gu	Director, Chief Technology Offier	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	50,000	150,000	-		-	Employee Stock Option (Right to buy)
Upstart Holdings Inc	Gu Paul	Director, Chief Technology Offier	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share.	02 Jan 2024	50,000	908,063	-	0.6	30,000	Common Stock
JBG SMITH Properties	George Laucks Xanders	Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	49,929	448,616	-		-	LTIP Units
JBG SMITH Properties	Xanders Laucks George	Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	49,782	398,687	-		-	LTIP Units
JBG SMITH Properties	Banerjee Madhumita Moina	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	49,004	267,675	-		-	LTIP Units
Procore Tech Inc	F. Craig Courtemanche	Director, CEO & President, Chairman of the Board	Sale of securities on an exchange or to another person at price $ 67.72 per share.	02 Jan 2024	48,851	2,998,257	-	67.7	3,308,190	Common Stock
Easterly Government Properties Inc	Ibe Michael P.	Director, EVP - Dev & Acquisitions	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	48,653	48,653	-		-	LTIP Units
ACV Auctions Inc (Class A)	Anderson Craig	CCDSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	48,297	239,823	-		-	Class A Common Stock
ACV Auctions Inc (Class A)	Anderson Craig	CCDSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	48,297	168,599	-		-	Class B Common Stock
ACV Auctions Inc (Class A)	Craig Anderson	CCDSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	48,297	50,000	-		-	Employee Stock Option (Right to Buy)
ACV Auctions Inc (Class A)	Anderson Craig	CCDSO	Sale of securities on an exchange or to another person at price $ 14.43 per share.	02 Jan 2024	48,297	191,526	-	14.4	696,926	Class A Common Stock
ACV Auctions Inc (Class A)	Craig Anderson	CCDSO		02 Jan 2024	48,297	120,302	-		-	Class B Common Stock
Gaming and Leisure Properties Inc	Ladany Steven L.	SVP Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	48,000	120,846 (0%)	0%		0	Common Stock
Alexandria Real Estate Equities Inc Results	S. Marcus Joel	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	47,620	398,974 (0%)	0%		0	Common Stock
Peabody Energy Corp - Ordinary Shares New	James C. Grech	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	47,406	287,844 (0%)	0%		0	Common Stock
Xcel Energy	Frenzel Robert C.	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	47,267	47,267	-		-	Restricted Stock Units
Kura Oncology Inc	Bair Teresa Brophy	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	46,250	71,032 (0%)	0%		0	Common Stock
Ginkgo Bioworks Holdings Inc (Class A)	Dmytruk Mark	See remarks		02 Jan 2024	45,794	716,098	-	1.5	70,523	Class A Common Stock
CEA Ind Inc	Mariathasan Marion	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	45,455	45,455	-		-	Common Stock-RSU
CEA Ind Inc	Nicholas J. Etten	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.55 per share.	02 Jan 2024	45,455	45,455	-	0.5	25,000	Common Stock
CEA Ind Inc	Nicholas J. Etten	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	45,455	45,455	-		-	Common Stock-RSU
CEA Ind Inc	Marion Mariathasan	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.55 per share.	02 Jan 2024	45,455	45,455	-	0.5	25,000	Common Stock
CEA Ind Inc	L. Reisner Troy	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.55 per share.	02 Jan 2024	45,455	45,455	-	0.5	25,000	Common Stock
CEA Ind Inc	L. Reisner Troy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	45,455	45,455	-		-	Common Stock-RSU
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Adam M. Aron	Director, Chairman, President & CEO		02 Jan 2024	45,095	90,195	-		-	Restricted Stock Units
Suburban Propane Partners LP - Unit Board Meeting	Stivala A. Michael	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 17.36 per share.	02 Jan 2024	45,000	288,291 (0%)	0%	17.4	781,425	Common Units (representing limited partnership interests)
Suburban Propane Partners LP - Unit Board Meeting	Michael A. Stivala	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 17.36 per share.	02 Jan 2024	45,000	288,291 (0%)	0%	17.4	781,425	Common Units (representing limited partnership interests)
Norwegian Cruise Line	Mark Kempa A.	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	44,652	285,673 (0%)	0%		0	Common Stock
Norwegian Cruise Line	Farkas S. Daniel	EVP, GC, CDO & Asst. Secy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	44,652	288,913 (0%)	0%		0	Common Stock
Norwegian Cruise Line	Harry Sommer	Director, Pres. & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	44,652	480,426 (0%)	0%		0	Common Stock
Bicycle Therapeutics PLC (ADR)	Nigel Crockett	Chief Business Officer		02 Jan 2024	44,000	44,000	-		-	Employee Stock Option (right to buy)
Coursera Inc	K. Shravan Goli	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.23 per share.	02 Jan 2024	43,753	853,276	-	2.2	97,569	Common Stock
Coursera Inc	K. Goli Shravan	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	43,753	87,498	-		-	Stock Option (right to buy)
Coursera Inc	Shravan Goli K.	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 19.15 per share.	02 Jan 2024	43,753	809,523	-	19.1	837,826	Common Stock
BlackBerry Ltd	Marjorie Dickman	Chief Gv Aff & Pub Pol Officer		02 Jan 2024	43,731	43,731	-		-	Restricted Share Units
WEC Energy	Gale E. Klappa	Director, Executive Chairman		02 Jan 2024	43,352	43,352	-		-	Stock Option (right to buy)
First Industrial Realty Trust Inc Results Board Meeting 10-year high	E Peter Baccile	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	43,322	306,180	-		-	LP Units
Ionis Pharma Inc	Cadoret-Manier Onaiza	EVP, Chf GL Pdt Str & Oper Ofc	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	43,200	43,200	-		-	Non-Qualified Stock Option (right to buy)
Ionis Pharma Inc	L. Hougen Elizabeth	EVP, Finance & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	43,200	43,200	-		-	Non-Qualified Stock Option (right to buy)
Bullfrog AI Holdings Inc	Vininder Singh	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 2.99 per share.	02 Jan 2024	43,056	2,549,390	-	3.0	128,647	Common Stock
Kura Oncology Inc	Doyle Thomas	SVP, Finance & Accounting	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	42,500	42,500	-		-	Option to purchase common stock
Exlservice Hldgs Inc	Ayyappan Ajay	EVP & Gen Counsel/Corp. Secy.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	42,100	75,714 (0%)	0%		0	Common Stock, par value $0.001 per share
Phreesia Inc	Chaim Indig	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	42,000	1,283,996 (3%)	0%		0	Common Stock
Whitehawk Therapeutics Inc	Neil Desai P.	Director, Executive Chairman	Sale of securities on an exchange or to another person at price $ 2.06 per share.	02 Jan 2024	42,000	1,495,543	-	2.1	86,549	Common Stock
Reliance Global Grp Inc 10-year low	Joel Markovits	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share.	02 Jan 2024	41,869	211,703 (0%)	0%	0.6	24,012	Common Stock
Modiv Inc (Class C)	Aaron Halfacre Scott	Director, CEO and President		02 Jan 2024	41,828	0	-		-	Class C OP Units
Modiv Inc (Class C)	Scott Aaron Halfacre	Director, CEO and President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	41,828	41,828	-		-	Class C OP Units
Modiv Inc (Class C)	Aaron Halfacre Scott	Director, CEO and President		02 Jan 2024	41,828	74,340	-		-	COMMON STOCK, CLASS C
Nextracker Inc (Class A)	D. Offer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	41,298	41,298	-		0	Common Stock
Sempra Energy	Sedgwick Karen L.	Executive VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	40,638	40,638	-		-	Employee Stock Option (right to buy)
Magnite Inc	Evans Katie	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	40,602	40,602	-		-	Performance Stock Units
Magnite Inc	Lee Soroca Adam	Chief Product Officer		02 Jan 2024	40,602	40,602	-		-	Performance Stock Units
PattersonUTI Energy Inc	Matthew R. Gillard	President-Completions		02 Jan 2024	40,406	211,382	-		-	Restricted Stock Units
PattersonUTI Energy Inc	Matthew R. Gillard	President-Completions		02 Jan 2024	40,406	118,631 (0%)	0%		0	Common Stock, $.01 par value per share
Equitable Holdings Inc	Pearson Mark	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	40,000	686,400	-		-	Employee Stock Option (right to buy)
Equitable Holdings Inc	Pearson Mark	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.74 per share.	02 Jan 2024	40,000	699,625 (0%)	0%	18.7	749,600	Common Stock
Photronics Inc	Christopher Progler J.	EVP, Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	40,000	231,464 (0%)	0%		0	Common Stock
Zentalis Pharma Inc High Gain High Volume	Mark Lackner	Chief Scientific Officer		02 Jan 2024	40,000	56,313	-		0	Common Stock
Edison International	Pedro J. Pizarro	Director, PRESIDENT AND CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	39,752	0	-		-	Restricted Stock Units
Edison International	J. Pizarro Pedro	Director, PRESIDENT AND CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	39,752	181,734 (0%)	0%		-	Common Stock
Gaming and Leisure Properties Inc	M. Carlino Peter	Director, Chairman,CEO,President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	39,476	5,883,028 (2%)	0%		0	Common Stock
Bicycle Therapeutics PLC (ADR)	Alistair Milnes	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	39,000	75,839	-		0	Ordinary Shares
MFA Fin Inc	Schwartz E. Harold	Senior Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	38,935	191,904	-		-	Phantom Shares
Sempra Energy	Bird Justin C.	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	38,913	38,913	-		-	Employee Stock Option (right to buy)
UDR Dividend	Lacy D. Michael	SVP-Property Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	38,731	282,801	-		-	Class 2 LTIP Units
Regenxbio Inc High Loss High Volume	Simpson Curran	Chief Oper. & Tech. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	38,462	123,327 (0%)	0%		0	Common Stock
Regenxbio Inc High Loss High Volume	Danos Olivier	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	38,462	124,853 (0%)	0%		0	Common Stock
Easterly Government Properties Inc	Baivier G. Meghan	President & COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	38,461	38,461	-		-	LTIP Units
HP Inc.	Enrique Lores J.	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 29.75 per share.	02 Jan 2024	38,000	888,911 (0%)	0%	29.8	1,130,500	Common Stock
Loews	M. Jonathan Tisch	Director, Co-Ch. of Bd/Off. of the Pres.		02 Jan 2024	37,850	129,020 (0%)	0%	69.7	2,636,253	Common Stock
Dyadic Intl Inc, DE	Ronen Tchelet	VP of Research and Bus. Dvlpmt	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	37,500	37,500	-		-	Stock Option
LXP Industrial Trust	Boulerice Beth	EVP, CFO and Treasurer	Sale or transfer of securities back to the company at price $ 9.92 per share.	02 Jan 2024	37,373	194,827 (0%)	0%	9.9	370,740	Common Shares
Kratos Defense & Security Soln Inc	H. Deanna Lund	Director, EVP & CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.53 per share.	02 Jan 2024	37,313	213,165 (0%)	0%	18.5	691,410	Common Stock
JBG SMITH Properties	Museles A. Steven	Chief Legal Off. & Corp Secy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	37,181	250,743	-		-	LTIP Units
EPR Properties	Gregory Silvers K.	Director, Chairman & CFO	Other type of transaction at price $ 48.45 per share.	02 Jan 2024	37,121	553,504 (0%)	0%	48.4	1,798,512	Common Shares of Beneficial Interest
Cardlytics Inc	Sosin Clifford	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 8.86 per share.	02 Jan 2024	37,000	5,379,116 (20%)	0%	8.9	327,698	Common Stock
Monte Rosa Therapeutics Inc	Dunn Edmund	Principal Accounting Officer		02 Jan 2024	35,900	35,900	-		-	Stock Option (Right to Buy)
Royalty Pharma PLC (Class A)	Riggs B. Rory	Director		02 Jan 2024	35,702	20,099	-	27.5	983,504	Class A Ordinary Shares
Spero Therapeutics Inc	Kathleen Tregoning	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	35,604	35,604	-		-	Stock Option (Right to Buy)
Bicycle Therapeutics PLC (ADR)	Santiago Arroyo	Chief Development Officer		02 Jan 2024	35,430	35,430	-		-	Employee Stock Option (right to buy)
Imax Corp Analyst Downgrade	L. Gelfond Richard	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.98 per share.	02 Jan 2024	35,180	438,993 (0%)	0%	15.0	526,996	common shares
Glaukos Corp	Thomas Burns W.	Director, CHAIRMAN & CEO	Sale of securities on an exchange or to another person at price $ 77.66 per share.	02 Jan 2024	35,086	63,985 (0%)	0%	77.7	2,724,779	Common Stock
Newmark Grp Inc (Class A)	Stephen M. Merkel	EVP and Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	02 Jan 2024	35,006	4,461 (0%)	0%		-	Class A Common Stock, par value $0.01 per share
Upstart Holdings Inc	Gu Paul	Director, Chief Technology Offier	Sale of securities on an exchange or to another person at price $ 39.01 per share.	02 Jan 2024	34,770	873,293	-	39.0	1,356,211	Common Stock
Regenxbio Inc High Loss High Volume	Christmas J. Patrick	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	34,615	115,759 (0%)	0%		0	Common Stock
MFA Fin Inc	Michael Roper C.	Sr VP & Chief Financial Ofcr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	34,609	130,801	-		-	Phantom Shares
Amplitude Inc (Class A)	Agrawal Neeraj	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 12.56 per share.	02 Jan 2024	33,333	327,766	-	12.6	418,662	Class A Common Stock
UDR Dividend	Grove Jon A.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	33,175	142,183	-		-	Class 1 Performance LTIP Units
UDR Dividend	King Mary Ann	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	33,175	67,280	-		-	Class 1 Performance LTIP Units
OmniAb Inc	Foehr W. Matthew	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	33,173	2,678,615	-		-	Common Stock
OmniAb Inc	W. Matthew Foehr	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	33,173	226,361	-		-	Restricted Stock Units
MongoDB Inc (Class A)	Ittycheria Dev C.	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share.	02 Jan 2024	33,000	231,166 (0%)	0%	6.5	214,500	Class A Common Stock
MongoDB Inc (Class A)	Ittycheria Dev C.	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	33,000	104,036	-		-	Employee Stock Option (Right to Buy)
Immunome Inc	A. Schafer Carol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	32,934	32,934	-		-	Stock option (right to buy)
Pagerduty Inc	Tejada G. Jennifer	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.92 per share.	02 Jan 2024	32,663	682,315 (0%)	0%	21.9	715,973	Common Stock
Spok Holdings Inc Board Meeting	D. Kelly Vincent	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	32,300	235,695	-		-	Restricted Stock Unit

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jan 02, 2024

Monitor US insider transactions and discover insider buying and selling of stocks on Jan 02, 2024.

The latest disclosure under SEC insider trading regulations was reported by Carrier Global Corp., where the revocation of 58,608,959 Common Stock of common stock was executed . This transaction was reported to the Securities and Exchange Commission on Jan. 2, 2024.

Screeners based on Insider Trading parameters